3-氟-4-硝基苯胺 | 2369-13-3

• 物质功能分类: 有机原料 - 烃类化合物及其衍生物 - 烃类硝化物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氟-4-硝基苯胺
• 中文别名: 4-硝基-3-氟苯胺
• 英文名称: 3-fluoro-4-nitroaniline
• CAS: 2369-13-3
• 化学式: C₆H₅FN₂O₂
• mdl: MFCD03412239
• 分子量: 156.116
• InChiKey: KKQPNAPYVIIXFB-UHFFFAOYSA-N

物化性质

• 熔点：
  152-157°C
• 沸点：
  335.2±22.0 °C(Predicted)
• 密度：
  1.448±0.06 g/cm3(Predicted)
• 溶解度：
  溶于甲醇
• 稳定性/保质期：
  避免让氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  71.8
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22
• 海关编码：
  2921420090
• WGK Germany：
  3
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302+H312+H332,H315,H319,H335
• 储存条件：
  请将容器密封后，放入一个密闭的储存器中，并存放在阴凉、干燥的地方。

SDS

3-Fluoro-4-nitroaniline Revision number: 5
SAFETY DATA SHEET

---

Section 1. IDENTIFICATION
Product name: 3-Fluoro-4-nitroaniline

Revision number: 5

---

Section 2. HAZARDS IDENTIFICATION
GHS classification
PHYSICAL HAZARDS Not classified
HEALTH HAZARDS
Acute toxicity (Oral) Category 4
Category 4
Acute toxicity (Dermal)
Acute toxicity (Inhalation) Category 4
Category 2
Skin corrosion/irritation
Serious eye damage/eye irritation Category 2A
Not classified
ENVIRONMENTAL HAZARDS
GHS label elements, including precautionary statements
Pictograms or hazard symbols
Signal word Warning
Harmful if swallowed, in contact with skin or if inhaled
Hazard statements
Causes skin irritation
Causes serious eye irritation
Precautionary statements:
Avoid breathing dust/fume/gas/mist/vapours/spray.
[Prevention]
Use only outdoors or in a well-ventilated area.
Do not eat, drink or smoke when using this product.
Wash hands thoroughly after handling.
Wear protective gloves and eye/face protection.
[Response] IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for
breathing. Call a POISON CENTER or doctor/physician if you feel unwell.
IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
Rinse mouth.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses,
if present and easy to do. Continue rinsing.
If eye irritation persists: Get medical advice/attention.
IF ON SKIN: Gently wash with plenty of soap and water.
If skin irritation occurs: Get medical advice/attention.
Wash contaminated clothing before reuse.
Call a POISON CENTER or doctor/physician if you feel unwell.
3-Fluoro-4-nitroaniline

---

Section 2. HAZARDS IDENTIFICATION
[Disposal] Dispose of contents/container through a waste management company authorized by
the local government.

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/mixture: Substance
Components: 3-Fluoro-4-nitroaniline
>95.0%(GC)
Percent:
CAS Number: 2369-13-3
Chemical Formula: C6H5FN2O2

---

Section 4. FIRST AID MEASURES
Inhalation: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
Call a POISON CENTER or doctor/physician if you feel unwell.
Skin contact: Remove/Take off immediately all contaminated clothing. Gently wash with plenty of
soap and water. If skin irritation or rash occurs: Get medical advice/attention.
Rinse cautiously with water for several minutes. Remove contact lenses, if present
Eye contact:
and easy to do. Continue rinsing. If eye irritation persists: Get medical
advice/attention.
Ingestion: Call a POISON CENTER or doctor/physician if you feel unwell. Rinse mouth.
Protection of first-aiders: A rescuer should wear personal protective equipment, such as rubber gloves and air-
tight goggles.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing Dry chemical, foam, water spray, carbon dioxide.
media:
Specific hazards arising Take care as it may decompose upon combustion or in high temperatures to
generate poisonous fume.
from the chemical:
Precautions for firefighters: Fire-extinguishing work is done from the windward and the suitable fire-extinguishing
method according to the surrounding situation is used. Uninvolved persons should
evacuate to a safe place. In case of fire in the surroundings: Remove movable
containers if safe to do so.
Special protective When extinguishing fire, be sure to wear personal protective equipment.
equipment for firefighters:

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, Use personal protective equipment. Keep people away from and upwind of spill/leak.
protective equipment and Entry to non-involved personnel should be controlled around the leakage area by
emergency procedures: roping off, etc.
Environmental precautions: Prevent product from entering drains.
Methods and materials for Sweep dust to collect it into an airtight container, taking care not to disperse it.
containment and cleaning Adhered or collected material should be promptly disposed of, in accordance with
up: appropriate laws and regulations.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Handling is performed in a well ventilated place. Wear suitable protective equipment.
Technical measures:
Prevent dispersion of dust. Wash hands and face thoroughly after handling.
Use a local exhaust if dust or aerosol will be generated.
Advice on safe handling: Avoid contact with skin, eyes and clothing.
Conditions for safe storage, including any
incompatibilities
Keep container tightly closed. Store in a cool and dark place.
Storage conditions:
Store under inert gas.
Store away from incompatible materials such as oxidizing agents.
Air-sensitive
Comply with laws.
Packaging material:
3-Fluoro-4-nitroaniline

---

Section 8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Engineering controls: Install a closed system or local exhaust as possible so that workers should not be
exposed directly. Also install safety shower and eye bath.
Personal protective equipment
Respiratory protection: Dust respirator. Follow local and national regulations.
Protective gloves.
Hand protection:
Eye protection: Safety glasses. A face-shield, if the situation requires.
Skin and body protection: Protective clothing. Protective boots, if the situation requires.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state (20°C): Solid
Form: Crystal- Powder
Yellow - Deep reddish yellow
Colour:
Odour: No data available
pH: No data available
Melting point/freezing point:161°C
Boiling point/range: No data available
Flash point: No data available
Flammability or explosive
limits:
Lower: No data available
Upper: No data available
Relative density: No data available
Solubility(ies):
No data available
[Water]
[Other solvents]
Soluble: Methanol

---

Section 10. STABILITY AND REACTIVITY
Chemical stability: Stable under proper conditions.
Possibility of hazardous No special reactivity has been reported.
reactions:
Incompatible materials: Oxidizing agents
Hazardous decomposition Carbon monoxide, Carbon dioxide, Nitrogen oxides (NOx), Hydrogen fluoride
products:

---

Section 11. TOXICOLOGICAL INFORMATION
Acute Toxicity: No data available
Skin corrosion/irritation: No data available
Serious eye No data available
damage/irritation:
Germ cell mutagenicity: No data available
Carcinogenicity:
No data available
IARC =
NTP = No data available
Reproductive toxicity: No data available

---

Section 12. ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: No data available
Crustacea: No data available
Algae: No data available
Persistence / degradability: No data available
Bioaccumulative No data available
potential(BCF):
Mobility in soil
3-Fluoro-4-nitroaniline

---

Section 12. ECOLOGICAL INFORMATION
Log Pow: No data available
Soil adsorption (Koc): No data available
Henry's Law No data available
constant(PaM3/mol):

---

Section 13. DISPOSAL CONSIDERATIONS
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system.
Observe all federal, state and local regulations when disposing of the substance.

---

Section 14. TRANSPORT INFORMATION
Hazards Class: Does not correspond to the classification standard of the United Nations
UN-No: Not listed

---

Section 15. REGULATORY INFORMATION
Safe management ordinance of dangerous chemical product (State Council announces on January 26, 2002
and revised on February 16,2011): Safe use and production, the storage of a dangerous chemical, transport,
loading and unloading were prescribed.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

简介

3-氟-4-硝基苯胺是一种黄色针状结晶，具有高毒性和易升华的特性。它微溶于冷水，并能溶解于沸水、乙醇、乙醚、苯和酸溶液中，是一种重要的有机合成原料。

用途

3-氟-4-硝基苯胺作为苯胺类化合物，广泛用作化工原料，可以直接用于合成多种染料和颜料。此外，它还可以合成农药氯硝胺及医药卡柳肿等产品；同时，在生产防老剂、光稳定剂和显影剂等方面也具有重要作用。

生产方法

工业上通常以3-氟-4-硝基氯苯为原料来生产3-氟-4-硝基苯胺。该过程可以通过高压釜间歇法进行，收率可达到98%以上；也可以采用管道反应器连续化生产，此时的收率为94%左右。

反应信息

• 作为反应物：
  描述：

  3-氟-4-硝基苯胺 在 palladium on activated charcoal 盐酸 、 乙醇 、 Bechamp-suspension 、 二氧化硫 、 水 、 氢气 、 铁粉 、 sodium carbonate 、 potassium carbonate 、 copper dichloride 、 sodium nitrite 作用下， 以 水 为溶剂， 反应 21.17h， 生成 对氨基苯磺酸
  参考文献：
  名称：

  Zur合成磺化酯衍生物von 2-Fluoranilin

  摘要：

  2-氟苯胺的磺化衍生物的合成

  DOI：

  10.1002/hlca.19830660108
• 作为产物：
  描述：

  3-氟苯胺 在 苯甲醛 、 硫酸 、 硝酸 作用下， 以 水 为溶剂， 反应 2.0h， 以35%的产率得到3-氟-4-硝基苯胺
  参考文献：
  名称：

  [EN] BROADSPECTRUM SUBSTITUTED BENZIMIDAZOLE SULFONAMIDE HIV PROTEASE INHIBITORS
  [FR] INHIBITEURS DE PROTEASE DE VIH A BASE DE BENZIMIDAZOLE SULFONAMIDE SUBSTITUES A LARGE SPECTRE

  摘要：

  本发明涉及具有以下式（I）的化合物，其中N-氧化物，盐，立体异构体形式，消旋混合物，前药，酯及其代谢物，其中R1和R8各自为H，可选择地取代的C1-6烷基，C2-6烯基，C3-7环烷基，芳基，Het1，Het2；R1也可以是具有式（R11aR11b）NC（R10aRl0b）CR9-的基团；t为0、1或2；R2为H或C1-6烷基；L为-C（=O）-，-O-C（=O）-，-NR8-C（=O）-，-O-C1-6烷二基-C（=O）-，-NR8-C1-6烷二基-C（=O）-，-S（=O）2-，-O-S（=O）2-，-NR8-S（=O）2；R3为C1-6烷基，芳基，C3-7环烷基，C3-7环烷基C1-4烷基，或芳基C1-4烷基；R4为H，C1-4烷基OC（=O），羧基，氨基C（=O），单或双（C1-4烷基）氨基C（=O），C3-7环烷基，C2-6烯基，C2-6炔基或可选择地取代的C1-6烷基；A为C1-6烷二基，-C（=O）-，-C（=S）-，-S（=O）2-，C1-6烷二基-C（=O）-，C1-6烷二基-C（=S）-或C1-6烷二基-S（=O）2-；R5为H，OH，C1-6烷基，Het1C1-6烷基，Het2C1-6烷基，可选择地取代的氨基-C1-6烷基；R6为C1-6烷氧，Het1，Het1O，Het2，Het2O，芳基，芳基O，C1-6烷氧基羰基氨基或氨基；如果A-不是C1-6烷二基，则R6也可以是C1-6烷基，Het1C1-4烷基，Het1OC1-4烷基，Het2C1-4烷基，Het2OC1-4烷基，芳基C1-4烷基，芳基OC1-4烷基或氨基C1-4烷基；在R6的定义中，每个氨基也可以选择性地被取代；R5和A-R6连同它们连接的氮原子一起也可以形成Het1或Het2，R12为H，-NH2，A-NR5AR6，-C1-6烷基或烷基-W-R14，其中所述烷基可选择性地用卤素，羟基，芳基，杂环芳基，Het1，Het2或氨基取代，其中所述氨基可选择性地单取代或双取代为C1-4烷基，R13为H，C1-6-烷基，可选择地被芳基，Het1，Het2，羟基，卤素，氨基取代，其中所述氨基可选择性地单取代或双取代为C1-4烷基。

  公开号：

  WO2003076413A1

文献信息

• Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20150231142A1

  公开（公告）日：2015-08-20

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及含有上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• [EN] QUINOLINE AND QUINAZOLINE COMPOUNDS<br/>[FR] COMPOSÉS QUINOLÉINE ET QUINAZOLINE
  申请人：ACERTA PHARMA BV

  公开号：WO2016055982A1

  公开（公告）日：2016-04-14

  In some embodiments, the invention relates to quinazoline and quinoline compounds of Formula I: (I) or a pharmaceutically acceptable salt thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, in some embodiments, the present invention relates to quinazoline and quinoline compounds, pharmaceutical compositions thereof, and the use of the compounds and pharmaceutical compositions in the treatment of Bruton's tyrosine kinase (BTK) mediated disorders.

  在某些实施例中，该发明涉及式I的喹唑啉和喹啉化合物：(I)或其药用可接受盐，或者涉及包含这些化合物的药物组合物以及它们在治疗中的应用。具体而言，在某些实施例中，本发明涉及喹唑啉和喹啉化合物、其药物组合物以及这些化合物和药物组合物在治疗布鲁顿氨基酸激酶（BTK）介导的疾病中的应用。
• COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
  申请人：Van Goor Fredrick F.

  公开号：US20110098311A1

  公开（公告）日：2011-04-28

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及包含上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• [EN] COMPOUNDS USEFUL AS CSF1 MODULATORS<br/>[FR] COMPOSÉS UTILES EN TANT QUE MODULATEURS DU FACTEUR 1 DE STIMULATION DE COLONIES
  申请人：REDX PHARMA PLC

  公开号：WO2016051193A1

  公开（公告）日：2016-04-07

  This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.

  这项发明涉及新颖化合物以及包含这些新颖化合物的药物组合物。更具体地，该发明涉及用作集落刺激因子1受体（cFMS）调节剂（例如cFMS抑制剂）的化合物。这项发明还涉及制备这些化合物的方法，这些化合物在治疗中的用途以及利用这些化合物进行治疗的方法。具体而言，该发明涉及利用这些化合物治疗癌症和自身免疫性疾病。
• [EN] 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE LA 3-PHOSPHOGLYCÉRATE DÉSHYDROGÉNASE ET LEURS UTILISATIONS
  申请人：RAZE THERAPEUTICS INC

  公开号：WO2017156181A1

  公开（公告）日：2017-09-14

  The present invention provides compounds, compositions thereof, and methods of using the same.

  本发明提供了化合物、其组合物以及使用这些化合物的方法。